Blackstone buys 60% shares in Japanese drug trial company

Blackstone buys 60% shares in Japanese drug trial company

Source: Michael Longmire/Unsplash

03 March, 2025

Edited by: Joymitra Rai

Printed by Unregistered user on Sun, 27 Jul 2025 10:07:28 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Blackstone offloads 25% stake in Indian packaging firm EPL for $220m

Novartis buys Blackstone-owned biopharma firm Anthos for $3b

Read more from Rest of Asia

Editor’s Take: The Week That Was—July 21-26

Mideast PE giant, veteran Chinese banker launch new investment platform